packageVedolizumab

vedolizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Vedolizumab is a monoclonal antibody immunosuppressant used to treat ulcerative colitis and Crohn's disease. It is authorised in the European Union and is also being investigated for other conditions such as graft-versus-host disease.

Summary written by glm-5.3-flash from Wikidata Q7918002 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:vedolizumab
ATC codes:L04AG05
DrugBank:DB09033
Wikidata:Q7918002
molar mass:146837 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown